市场调查报告书
商品编码
1452594
北美家禽诊断市场预测至 2030 年 - 区域分析 - 按测试类型和疾病(禽沙门氏菌病、禽流感、新城疫、禽支原体病、传染性支气管炎等)North America Poultry Diagnostic Market Forecast to 2030 - Regional Analysis - By Test Type and Disease (Avian Salmonellosis, Avian Influenza, Newcastle Disease, Avian Mycoplasmosis, Infectious Bronchitis, and Others) |
北美家禽诊断市场预计将从2022年的1.1889亿美元成长到2030年的2.5367亿美元。预计2022年至2030年CAGR为9.9%。
农场现场诊断家禽平台推动北美家禽诊断市场
如今,在感染率较高的农场现场安装了简单的农场端分子诊断平台和补充监测软体,透过对家禽动物进行病毒和细菌病原体检测来遏制疾病传播。此外,家禽产业团队可以在短时间内成功开发出符合世界卫生组织 (WHO) 指南的便携式、电池供电、独立的诊断平台,以确保这些设备可以在农场的任何地方运行,从而消除了需要实验室结构、训练有素的人员和附加设备。此外,该设备的成本比同类商用设备低 95%,并根据具有同等标准的黄金标准设备进行了验证。因此,实施此类农场家禽疾病诊断平台将有助于农民透过早期发现和遏制来控制传染病、抗菌素抗药性(AMR)和人畜共通病原体的传播。
北美洲家禽诊断市场概况
北美家禽诊断市场分为美国、加拿大和墨西哥。 2022年,美国在该地区占据最大的市场份额,并且由于家禽衍生产品的消费不断增加以及消费者食品安全意识不断增强,预计在预测期内将继续保持主导地位。此外,根据联合国粮食及农业组织(UNFAO)公布的统计数据,2022年北美鸡蛋和母鸡产量均增加。
北美家禽诊断市场收入及 2030 年预测(百万美元)
北美家禽诊断市场细分
北美家禽诊断市场分为测试类型、疾病和国家。
根据测试类型,北美家禽诊断市场分为酵素连结免疫吸附测定(ELISA)测试、聚合酶链反应(PCR)测试、血凝抑制(hi)测试等。 2022 年,酶联免疫吸附测定 (ELISA) 测试领域占据北美家禽诊断市场的最大份额。
根据疾病,北美洲家禽诊断市场分为禽流感、传染性支气管炎、禽沙门氏菌病、新城疫、禽支原体病等。 2022 年,禽流感细分市场占据北美家禽诊断市场的最大份额。
根据国家/地区,北美家禽诊断市场分为美国、加拿大和墨西哥。 2022 年,美国将主导北美家禽诊断市场。
Thermo Fisher Scientific Inc、Idex Laboratories Inc、Qiagen NV、Eurofins Scientific SE、Boehringer Ingelheim International GmbH、Zoetis Inc、BioCheck BV 和 Bioneer Corp 是北美家禽诊断市场上的一些领先公司。
The North America poultry diagnostic market is expected to grow from US$ 118.89 million in 2022 to US$ 253.67 million by 2030. It is estimated to grow at a CAGR of 9.9% from 2022 to 2030.
Farm-Side Diagnostic Poultry Platform Fuel North America Poultry Diagnostic Market
Nowadays, a simple farm-side molecular diagnostic platform and complementary surveillance software are installed at the farm site with a high infection rate to curb the spread of disease by test poultry animals for viral and bacterial pathogens. Also, within a short span the poultry industry team can successfully develop a portable, battery-powered, stand-alone diagnostic platform abiding by World Health Organization (WHO) guidelines to ensure that these devices can be operated anywhere on the farm, eliminating the need for laboratory structure, trained personnel, and additional equipment. Also, the cost of the device is 95% lower than comparable commercially available devices and validated against gold standard devices showing equivalent standards. Therefore, implementation of such farm-side poultry disease diagnostic platforms would help farmers keep a check on the spread of infectious disease, antimicrobial resistance (AMR), and zoonotic pathogens by enabling early detection and containment.
North America Poultry Diagnostic Market Overview
The North America poultry diagnostics market is segmented into the US, Canada, and Mexico. In 2022, the US held the largest market share in this region and is expected to continue its dominance during the forecast period due to the increasing consumption of poultry-derived products and growing consumer awareness regarding food safety. Moreover, as per the statistics published by the United Nations Food and Agriculture Organization (UNFAO), in 2022, there was an increase in the production of eggs and hens in North America.
North America Poultry Diagnostic Market Revenue and Forecast to 2030 (US$ Million)
North America poultry diagnostic market Segmentation
The North America poultry diagnostic market is segmented into test type, disease, and country.
Based on test type, the North America poultry diagnostic market is segmented into enzyme-linked immunosorbent assay (ELISA) tests, polymerase chain reaction (PCR) tests, hemagglutination-inhibition (hi), and others. The enzyme-linked immunosorbent assay (ELISA) tests segment held the largest share of the North America poultry diagnostic market in 2022.
Based on disease, the North America poultry diagnostic market is segmented into avian influenza, infectious bronchitis, avian salmonellosis, Newcastle disease, avian mycoplasmosis, and others. The avian influenza segment held the largest share of the North America poultry diagnostic market in 2022.
Based on country, the North America poultry diagnostic market is segmented into the US, Canada, and Mexico. The US dominated the North America poultry diagnostic market in 2022.
Thermo Fisher Scientific Inc, Idexx Laboratories Inc, Qiagen NV, Eurofins Scientific SE, Boehringer Ingelheim International GmbH, Zoetis Inc, BioCheck BV, and Bioneer Corp are some of the leading companies operating in the North America poultry diagnostic market.